Is a complete VRDN research report available?

No complete published report is available for Viridian Therapeutics, Inc. (VRDN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Viridian Therapeutics, Inc. (VRDN)

NASDAQ: VRDN · USD

$24.3

+0.23 (+0.9%)· Recorded snapshot

Market cap	2.8B
Revenue (ttm)	71.1M
Net income (ttm)	-334M
EPS (ttm)	-$3.46
Shares out	113.3M
Volume	1,102,479
Beta	1.10

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 71.1M
Net income (ttm): -334M
EPS (ttm): -$3.46
Market cap: 2.8B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001590750
Company name	Viridian Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	92790C104
Earnings date	2026-11-04
Earnings time	bmo
Employees	252
Employees change	109
Employees growth	76.22%
Enterprise value	$2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2006
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US92790C1045
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2020-11-13
Last stock split type	Reverse
Market cap	$2.8B
Market cap category	Mid-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$24.32
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	VRDN
U.S. state	Massachusetts
Website	https://www.viridiantherapeutics.com

Metric

Value

Amount currency

USD

CIK code

0001590750

Company name

Viridian Therapeutics, Inc.

Country

United States

Country code

CUSIP number

92790C104

Earnings date

2026-11-04

Earnings time

bmo

Employees

252

Employees change

109

Employees growth

76.22%

Enterprise value

$2B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2006

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US92790C1045

Last 10-K release date

2026-02-26

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2020-11-13

Last stock split type

Reverse

Market cap

$2.8B

Market cap category

Mid-Cap

Next earnings date

2026-11-04

Options

Yes

Price

$24.32

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

VRDN

U.S. state

Massachusetts

Website

https://www.viridiantherapeutics.com

Metric	Value
Earnings yield	-14.22%
EV/Sales	27.71x
FCF / EV yield	-17%
FCF yield	-12.37%
Forward EV/Sales	14.73x
Forward P/S	20.24x
P/B ratio	4.84x
P/S ratio	38.07x
Price / tangible book value	4.89x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-14.22%

EV/Sales

27.71x

FCF / EV yield

-17%

FCF yield

-12.37%

Forward EV/Sales

14.73x

Forward P/S

20.24x

P/B ratio

4.84x

P/S ratio

38.07x

Price / tangible book value

4.89x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Operating margin	-569.68%
Pretax margin	-544.06%
Profit per employee	$-1.3M
Revenue per employee	$282,250
ROA	-30.16%
ROA (5Y)	-29.68%
ROCE	-39.21%
ROE	-65.74%
ROE (5Y)	-50.12%
ROIC	-35.05%
SBC / revenue	75.38%

Metric

Value

Operating margin

-569.68%

Pretax margin

-544.06%

Profit per employee

$-1.3M

Revenue per employee

$282,250

ROA

-30.16%

ROA (5Y)

-29.68%

ROCE

-39.21%

ROE

-65.74%

ROE (5Y)

-50.12%

ROIC

-35.05%

SBC / revenue

75.38%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth	23,220.33%
Revenue growth (Q)	278.67%
Revenue growth (QoQ)	101.42%
Revenue growth 10Y	30.4%
Revenue growth 3Y	264.39%
Revenue growth 5Y	93.9%
Revenue growth quarters	5
Revenue growth years	1

Metric

Value

EPS growth years

Net income growth years

Revenue growth

23,220.33%

Revenue growth (Q)

278.67%

Revenue growth (QoQ)

101.42%

Revenue growth 10Y

30.4%

Revenue growth 3Y

264.39%

Revenue growth 5Y

93.9%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-1.7M
Depreciation and amortization	$468,000
EBIT	$-405.2M
EBITDA	$-404.7M
EPS	$-3.46
FCF per share	$-2.96
Financing cash flow	$748.2M
Free cash flow	$-335M
Free cash flow minus SBC	$-388.7M
Gross profit	$-253.5M
Investing cash flow	$-367.2M
Net borrowing	$224.2M
Net cash flow	$47.7M
Net income	$-334M
Operating cash flow minus SBC	$-387M
Operating income	$-405.2M
Revenue	$71.1M
Stock-based compensation	$53.6M

Metric

Value

Capital expenditures

$-1.7M

Depreciation and amortization

$468,000

EBIT

$-405.2M

EBITDA

$-404.7M

EPS

$-3.46

FCF per share

$-2.96

Financing cash flow

$748.2M

Free cash flow

$-335M

Free cash flow minus SBC

$-388.7M

Gross profit

$-253.5M

Investing cash flow

$-367.2M

Net borrowing

$224.2M

Net cash flow

$47.7M

Net income

$-334M

Operating cash flow minus SBC

$-387M

Operating income

$-405.2M

Revenue

$71.1M

Stock-based compensation

$53.6M

Metric	Value
Altman Z-Score	0.93
Book value per share	$4.98
Debt / equity	0.37
Interest coverage	-25.95
Long-term assets	$16M
Long-term liabilities	$371.3M
Net cash (debt)	$736.8M
Net cash / market cap	27.21%
Net cash growth	36.37%
Net debt / equity	-1.11
Piotroski F-Score	4
Property, plant and equipment	$4.9M
Shareholders' equity	$662.1M
Tangible book value	$554.1M
Tangible book value per share	$4.89
Total assets	$1.1B
Total cash	$981.5M
Total debt	$244.7M
Total liabilities	$435.1M
WACC	9.89%

Metric

Value

Altman Z-Score

0.93

Book value per share

$4.98

Debt / equity

0.37

Interest coverage

-25.95

Long-term assets

$16M

Long-term liabilities

$371.3M

Net cash (debt)

$736.8M

Net cash / market cap

27.21%

Net cash growth

36.37%

Net debt / equity

-1.11

Piotroski F-Score

Property, plant and equipment

$4.9M

Shareholders' equity

$662.1M

Tangible book value

$554.1M

Tangible book value per share

$4.89

Total assets

$1.1B

Total cash

$981.5M

Total debt

$244.7M

Total liabilities

$435.1M

WACC

9.89%

Metric	Value
Asset turnover	0.08
Current assets	$1.1B
Current liabilities	$63.8M
Current ratio	16.95
Net working capital	$36.7M
Quick ratio	16.56
Working capital	$1B
Working capital turnover	0.09

Metric

Value

Asset turnover

0.08

Current assets

$1.1B

Current liabilities

$63.8M

Current ratio

16.95

Net working capital

$36.7M

Quick ratio

16.56

Working capital

$1B

Working capital turnover

0.09

Metric	Value
Buyback yield / dilution	-24.83%
Dividend yield	0%
Shareholder yield	-24.83%

Metric

Value

Buyback yield / dilution

-24.83%

Dividend yield

Shareholder yield

-24.83%

Metric	Value
150-day SMA	$19.11
1D price change	0.95%
1M price change	18.03%
1M total return	18.03%
1W price change	7.71%
1W total return	7.71%
1Y price change	7.19%
1Y return CAGR	7.19%
1Y total return	7.19%
20-day SMA	$20.37
200-day SMA	$21.84
3M price change	22.64%
3M total return	22.64%
3Y price change	95.15%
3Y return CAGR	24.96%
3Y total return	95.15%
50-day SMA	$21.65
50-day SMA vs 200-day SMA	50under200
52-week high	$34.29
52-week high date	2026-01-14
52-week low	$13.18
52-week low date	2026-04-29
5Y price change	34.9%
5Y return CAGR	6.17%
5Y total return	34.9%
6M price change	78.96%
6M total return	78.96%
All-time high	$270.00
All-time high date	2017-03-03
All-time low	$4.67
All-time low date	2020-03-19
Average true range (ATR)	$0.97
Average volume	2.1M
Beta (1Y)	-0.22
Beta (2Y)	0.66
Beta (5Y)	1.1
Change from 52-week high	-29.08%
Change from 52-week low	84.52%
Change from all-time high	-91.05%
Change from all-time low	417.9%
Change from open	1.97%
Day's gap	-1%
Dollar volume	$26.8M
High price	$24.42
Low price	$23.72
Monthly RSI	54.03
Open price	$23.85
Position in 52-week range	85.71%
Premarket change	-0.42%
Premarket close	$24.09
Premarket price	$23.99
Premarket volume	2.2K
Previous close	$24.09
Price vs 150-day SMA	26.45%
Price vs 20-day SMA	18.61%
Price vs 200-day SMA	10.64%
Price vs 50-day SMA	11.59%
Relative volume	0.53
RSI	68.63
Sharpe ratio	0.41
Sharpe ratio (3Y)	0.66
Sharpe ratio (5Y)	0.39
Sortino ratio	0.67
Sortino ratio (3Y)	1.1
Sortino ratio (5Y)	0.71
Volume	1.1M
Weekly RSI	57.57
YTD price change	-22.37%
YTD total return	-22.37%

Metric

Value

150-day SMA

$19.11

1D price change

0.95%

1M price change

18.03%

1M total return

18.03%

1W price change

7.71%

1W total return

7.71%

1Y price change

7.19%

1Y return CAGR

7.19%

1Y total return

7.19%

20-day SMA

$20.37

200-day SMA

$21.84

3M price change

22.64%

3M total return

22.64%

3Y price change

95.15%

3Y return CAGR

24.96%

3Y total return

95.15%

50-day SMA

$21.65

50-day SMA vs 200-day SMA

50under200

52-week high

$34.29

52-week high date

2026-01-14

52-week low

$13.18

52-week low date

2026-04-29

5Y price change

34.9%

5Y return CAGR

6.17%

5Y total return

34.9%

6M price change

78.96%

6M total return

78.96%

All-time high

$270.00

All-time high date

2017-03-03

All-time low

$4.67

All-time low date

2020-03-19

Average true range (ATR)

$0.97

Average volume

2.1M

Beta (1Y)

-0.22

Beta (2Y)

0.66

Beta (5Y)

1.1

Change from 52-week high

-29.08%

Change from 52-week low

84.52%

Change from all-time high

-91.05%

Change from all-time low

417.9%

Change from open

1.97%

Day's gap

-1%

Dollar volume

$26.8M

High price

$24.42

Low price

$23.72

Monthly RSI

54.03

Open price

$23.85

Position in 52-week range

85.71%

Premarket change

-0.42%

Premarket close

$24.09

Premarket price

$23.99

Premarket volume

2.2K

Previous close

$24.09

Price vs 150-day SMA

26.45%

Price vs 20-day SMA

18.61%

Price vs 200-day SMA

10.64%

Price vs 50-day SMA

11.59%

Relative volume

0.53

RSI

68.63

Sharpe ratio

0.41

Sharpe ratio (3Y)

0.66

Sharpe ratio (5Y)

0.39

Sortino ratio

0.67

Sortino ratio (3Y)

1.1

Sortino ratio (5Y)

0.71

Volume

1.1M

Weekly RSI

57.57

YTD price change

-22.37%

YTD total return

-22.37%

Metric	Value
Float	100.8M
Float percentage	88.96%
Shares change (QoQ)	5.55%
Shares change (YoY)	24.83%
Shares held by insiders	0.08%
Shares held by institutions	108.86%
Shares outstanding	113.3M
Short % of float	17.83%
Short % of shares	15.86%
Short ratio	10.9 days

Metric

Value

Float

100.8M

Float percentage

88.96%

Shares change (QoQ)

5.55%

Shares change (YoY)

24.83%

Shares held by insiders

0.08%

Shares held by institutions

108.86%

Shares outstanding

113.3M

Short % of float

17.83%

Short % of shares

15.86%

Short ratio

10.9 days

Viridian Therapeutics, Inc. (VRDN)

Price

Financial snapshot

Fair-value bridge

Latest news · VRDN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VRDN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VRDN

Frequently asked questions